Additionally, the endogenous bioactive lipid, Lipoxin A4 (LXA4), was shown to inhibit TGF‐β mediated differentiation of PSCs and reduced tumor growth with a significant reduction in collagen1 expression and fibrosis [9]. This evidence concerns the gene TGFB1 and neoplasm.